Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 16682686.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors examined cognitive performance change in 101 individuals with advanced HIV infection on highly active antiretroviral therapy (HAART), using standard neuropsychological testing in three visits, over a 27-month-period. Cognitive performance stabilized in a majority of HIV+ participants over time. A neuroactive HAART regimen was associated with neuropsychological improvement. Decline occurred in a minority with lower nadir CD4. The current CD4 count and plasma viral load were not associated with cognitive change.
Medical subject headings
- AIDS Dementia Complex
- Anti-HIV Agents
- Antiretroviral Therapy, Highly Active